Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Director departure

Eiger BioPharmaceuticals, Inc. (EIGR) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2019 8-K/A Quarterly results
06/17/2016 8-K/A Financial Statements and Exhibits Interactive Data
Docs: "Consent of KPMG LLP, Private Eiger's independent registered public accounting firm",
"Audited financial statements of Private Eiger as of December 31, 2015 and 2014 and for each of the three years ended December 31, 2015, 2014 and 2013"
05/13/2016 8-K/A Financial Statements and Exhibits
Docs: "Consent of KPMG LLP, Private Eiger's independent registered public accounting firm",
"Audited financial statements of Private Eiger as of December 31, 2015 and 2014 and for each of the three years ended December 31, 2015, 2014 and 2013",
"Unaudited pro forma condensed combined financial information of the Company and Private Eiger as of and for the year ended December 31, 2015"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy